Matthew McManus

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew McManus:

Company Role Class Num Shares Value Price $ Report Date Ownership
Azenta, Inc. EVP & Chief Operating Officer COMMON 29,467 $1,667,832 $56.60 19 Aug 2022 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Stock Option (Right to Buy) 24,614 $1,447,549 $58.81 01 Feb 2026 Direct
Azenta, Inc. EVP & Chief Operating Officer Common Stock 20,842 $1,208,002 $57.96 24 Jan 2022 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Performance Restricted Stock Units 19,243 $1,131,680 $58.81 01 Feb 2026 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Common Stock 7,691 $492,916 $64.09 01 Feb 2026 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Performance Stock Option (Right to Buy) 7,951 $467,598 $58.81 01 Feb 2026 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Restricted Stock Units 4,620 $271,702 $58.81 01 Feb 2026 Direct

Insider Reports Filed by Matthew McManus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TECH BIO-TECHNE Corp 01 Feb 2026 3 -$106,710 4 President - Diag & Spatial Bio 03 Feb 2026, 17:04
TECH BIO-TECHNE Corp 15 Aug 2025 6 -$47,168 4 President - Diag & Spatial Bio 19 Aug 2025, 17:28
TECH BIO-TECHNE Corp 01 Feb 2025 3 -$120,769 4 President - DGS 04 Feb 2025, 17:31
TECH BIO-TECHNE Corp 15 Aug 2024 1 $0 4/A President - DGS 03 Feb 2025, 16:38
TECH BIO-TECHNE Corp 01 Feb 2024 4 $0 4 President - DGS 05 Feb 2024, 18:35
TECH BIO-TECHNE Corp 08 Jan 2024 0 $0 3 President - DGS 05 Feb 2024, 18:34
AZTA Azenta, Inc. 19 Aug 2022 1 +$501,544 4 EVP & Chief Operating Officer 22 Aug 2022, 16:10
AZTA Azenta, Inc. 24 Jan 2022 0 $0 3 EVP & Chief Operating Officer 02 Feb 2022, 16:24